SANA compared with MCRB: revenue, margins and what each company keeps, and the suppliers and customers both name

SANASana Biotechnology, Inc.

Mkt capRevenueRevenue

MCRBSeres Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SANASana Biotechnology, Inc.

MCRBSeres Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SANA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±28.3%▲+4.99%×0.18

May 12 '26±29.1%▼−8.43%×0.29

Q1 FY26±23.8%▼−2.80%×0.12

Q3 FY25±28.0%▲+0.99%×0.04

MCRB1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±41.0%▼−4.67%×0.11

= impliedSANA realized, solidMCRB realized, hatchedOne scale, both sides: full bar = 42%× = |realized| ÷ impliedSource: market data

SANASana Biotechnology, Inc.

2.45▼−4.79%

Mkt cap$769.4MRevenue—

MCRBSeres Therapeutics, Inc.

1.83▲+3.64%

Regular sessionSep 2 '83

Mkt cap$17.6MRevenue$736,000Q2 FY26

Compare

Regular sessionSep 2 '83

SANASana Biotechnology, Inc.

MCRBSeres Therapeutics, Inc.

2.45▼−4.79%

Price

1.83▲+3.64%

$769.4M

Mkt cap

$17.6M

—

Revenue

$736,000Q2 FY26

SANA2.45▼−4.79%vsMCRB1.83▲+3.64%Regular sessionSep 2 '83